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Abstract 
Review on r(8) in hematological malignancies with 
clinical data, structural dynamics and critical genes 
involved. 
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induced genetic aberrations. 
Identity 
r(8) occurs more often in myeloid than in lymphoid 
malignancies. Unlike in solid tumors, where r(8) has 
shown to contain material from other chromosomes 
(Bernardino J et al, 1998, Pedeutour F et al, 2000, 
Nishio et al, 2001), r(8) in hematological 
malignancies are of a singular origin (Gebhart 2008). 
Clinics and pathology 
Disease 
Refractory Anemia with excessive blasts (RAEB), 
Acute Myeloid Leukemia (AML), common-Acute 
Lymphoid Leukemia (c-ALL), T cell 
Prolymphocytic Leukemia (T-PLL), Small cell B - 
Non-Hodgkins lymphoma (B-NHL), Radiation and 
chemotherapy induced genetic aberrations 
Phenotype/cell stem origin 
9 cases out of 15 were AML (Morgan R et al, 1985, 
Gisselsson D et al, 1999, Nakanishi M et al, 1999, 
Lindvall C et al, 2000, Berger R et al, 2002, 
Rothlisberger B et al, 2007, Kar B et al, 2008, Ashok 
V et al, 2016 ), with  M2 being the most common 
subtype. 2 cases were RAEB (Fugazza G et al, 1996, 
Keung YK et al, 1997). One case each of c-ALL 
(Edelhauser M et al, 2000), T-PLL (Oliveria F.M et 
al, 2007) and B-NHL (Wlodarska I et al, 2004) have 
been reported (Table 1). 
TABLE 1: Summary of 15 cases of Hematological malignancies with r(8) 
Sex/Ag
e 
Primary  
diagnos
is 
Karyotype  
(pretreatment) 
Karyotype  
(post treatment) 
ring 8 details  
Outco
me 
Authors 
M/8m  
ANLL 
M4  
46,XY/46,XY,del(13)(q14q22),1p +, - 8, + r(8) 
46,XY/46,XY,del(13)(q14q22)
,1p+, - 8, +r(8),- 10,19q+  
-8,+r(8)  UF  
Morgan 
R  et 
al, 1985 
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M/65  RAEB  
Pseudodiploid karyotype with structural 
abnormalities and a ring chromosome 
46, XY, 
del(5)(q13q31),t(7;20)(q22;p
13),-8,+r.  
-8,+r(8) with 
telomere 
deletion  
UF  
Fugazza et 
al, 1996 
M/74  RAEB  
48,XY,del(7)(q21),+?r(8)(p23q24.1), 
+add(21)(q12) /47,idem,-
Y,add(20)(q13)/48,idem,del(17)(p12), 
add(20)(q13)/46,idem,12,add(13)(p11.2),-
16,del(17)(p12), -19,add(20)(q13), +mar,3dmin 
-  
+?r(8)(p23q24
.1)  
UF  
Keung YK et 
al, 1997 
F/73  
AML 
M1  
45-47,XX,del(5)(q13),-8,+1-2r,+mar[cp15]/72-
76,XXX,+5, del(5)(q13)x2,-7,-8,-9,+13,-
16,+19,+20,+mar/46,XX  
-  
8q22 
amplification 
with presence 
of 8p 
subtelomeric 
sequences.  
-  
D Gisselsson 
1999  
-/72  
AML 
M2  
48,XY,-1,+del(1)(p12p22)X2,t(8;18)(p11;p11),-
11,+der(18)t(8;18)(p11;p11),del(20)(q11),+r  
-  
amplification 
of 8q24  
-  
Nakanishi et 
al, 1999 
F/32  c-ALL  
46 48,XX, r(8)(p?23q?22 24) 2,der(9;22)/46-
48,idem,ins(2;8)(q13;p?23q?22- 24)/46, XX 
-  
 r(8)(p?23;q?2
2-24) X2  
UF  
Edelhauser 
et al, 2000 
-  
AML 
M2  
45,X,-X,r(8),t(8;21)(q22;q22)/46,idem, i(22)(p10) -  -  -  
Florence 
Salomon-
Nguyen et 
al, 2000 
M/74  
AML 
M5  
46,XY,der(7)t(7;8)(q31;p11),del(8)(q23),t(12;13)(
p13;q21),  
der(16)t(8;16)(q23;q23)/47-
48,idem,r(8)(p11q21)x2 
-  
r(8)(p11q21)x 
2  
UF  
Lindvall C et 
al 2000 
F/19  
AML 
M2  
46,XX,-8,t(8;21),+r.  -  -8,+r(8)  F  
Berger R et 
al, 2002 
F/71  
Small 
cell B-
NHL  
46,XX,t(2;11)(p11;q13)/46,idem, del(1)(q22q42), 
r(8) 
  
r(8) negative 
for 8p23 loci 
by FISH  
UF  
Wlodarska 
et al, 2004 
M/41  T-PLL  
46,t(X;14)(q28;q11), t(Y;14)(q12;q11), 
r(8)(::qterfiq10::q10fi qter::), +mar 
46,XY  r [i(?8)(q10)]  -  
Oliveria F.M 
et al, 2007 
F/61  
AML 
M2  
47,XX,+r(8)/48,XX,+2r/ 46,XX -  
ring consists 
of amplified 
8q24/MYC  
-  
Rothlisbere
ger B et al, 
2007 
F/1  
AML 
M7  
46,XX/47,XX,+8/ 47,XX,+r(8) 46,XX  +r(8) UF  
Kar B et al, 
2008 
F/70  
AML 
M2  
47,XX,r(8)(p23q24) -  +r(8)(p23q24) UF  
Ashok V et 
al, 2016 
UF: Unfavorable, F: Favorable 
 
Epidemiology 
There were 5 male and 7 female patients with a 
median age of 63 years (range: 1 to 84 years), among 
them 2 were infants (5 months and 15 months) and 
only 1 pediatric case (19 years) was observed. The 
age of the adult patients ranged from 32 to 84 years, 
with a mean age of 65 years. 
Clinics 
Analysis of 15 cases of r(8) revealed a predominance 
in myeloid when compared to lymphoid 
malignancies. 12 patients in the study have presented 
with leukemia (AML, c-ALL, NHL, T-PLL) and 
only 2 were in pre-leukemic stage (RAEB) 
r(8)  
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indicating that r(8) is a marker for leukemic 
condition or "in-transformation" (Fig:1).  These 
findings are in concordance with the review by 
Gebhart E, 2008.  
 
Patients exposed to radiation have also been found to 
harbor r(8). Nakanishi et al reported a patient 
diagnosed with AML who was an atomic bomb 
survivor. Note: r(8) was also identified in  a patient 
with prostate cancer exposed to chemotherapy and 
therapeutic radiation in stimulated lymphocytes 
derived from the peripheral blood (Sabine et al 
2013). 
Cytology 
No characteristic cytological pattern was observed in 
the cases reported. However, a high percentage of 
blast count was observed in 60% of the cases. The 
median white blood count was 17 x109/L. The median 
platelet count was 31 x109/L. The median 
hemoglobin level was 10.35 g/dL 
Genes 
More than 65% of the cases had gain of chromosome 
8 either by partial trisomy or gene amplification. 
Genes with possible significance in leukemogenesis 
located on chromosome 8 include MYC on 8q24, 
KAT6A (MOZ) on 8p11 (Koskinen PJ et al), MOS 
on 8q22 (Diaz MO et al) and RUNX1T1 (ETO) on 
8q22 (Wang J). Role of TRIB1 independently has 
been associated in myeloid cell transformation and 
accelerates progression of HOXA9/ MEIS1-induced 
AML (Nakamura T et al, 2015). It is also observed 
to be associated with MYC amplification as 
represented in a case of AML by Rothlisberger B et 
al, 2006. 
Treatment 
A case of AML treated with interferon-e and 
granulocyte colony-stimulating factor showed no 
improvement with patient succumbing to sepsis 
(Fugazza G et al, 1996). Similarly another case of 
AML-M2 treated with hydroxyurea also had 
unfavorable outcome (Ashok V et al, 2016). But in a 
case of AML-M2, treatment with polychemotherapy 
(Protocol LAME 91) resulted in complete remission 
(Berger R et al, 2002). This is attributed to the 
presence of a good prognostic indicator in addition 
to r(8). In a case of AML-M7, UK MRC AML 
protocol resulted in hematologic and cytogenetic 
remission. Patient developed acute myelofibrosis 
followed by high-risk transplantation using 
unrelated cord blood stem cells. Patient died 11 days 
after transplant (Kar B et al, 2008).  
 
In a case of T-ALL, two cycles of Chlorambucil (4 
mg/day) and Fludarabine (25 mg/m2) had no 
improvement. A change in treatment protocol with 
seven weekly doses of Campath-1H (30 mg), 
resulted in complete regression of lymphadenopathy 
and hepatosplenomegaly with hematologic 
remission (Oliveria F.M et al, 2007).  In another case 
of ALL, complete hematologic remission was 
achieved after treatment according to the GMALL-
protocol (Vincristine, Daunorubicin, Asparaginase, 
and Prednisolone) and HAM (high-dose Cytarabine 
and Mitoxantrone) as consolidation therapy. Due to 
relapse, the patient was treated by fractionated high-
dose whole body irradiation (13.2 Gy) and high-dose 
chemotherapy (Cyclophosphamide) followed by 
allogeneic peripheral stem cell transplantation. The 
patient developed refractory pancytopenia and died 
of terminal cachexia (Edelhauser et al, 2000) 
Prognosis 
Presence of ring chromosomes in hematological 
malignancies can influence disease progression and 
clinical outcome due to heterogeneity in size, origin 
and genes involved. Solid tumors exhibit a higher 
incidence of ring chromosomes with greater 
complexities in their structure. (Gisselson, 1998, 
Gebhart, 2008).  
 
Presence of r(8) in hematological malignancies 
results in gain of chromosome 8 in majority of cases 
(see below). Trisomy 8 is the most common 
numerical abnormality in myeloid malignancies and 
is associated with intermediate to poor outcome 
(Heim S, Mitelman F, 2009). Presence of other 
prognostic markers appear to be the driving factor in 
disease progression rather than r(8). This is 
represented in a case of AML, where presence of 
t(8;21) with a r(8) had favorable outcome. 
Conversely, in a case of Ph positive ALL with r(8), 
patient went into early relapse with high blast count. 
Similarly in a case of RAEB with deletion of 7q and 
r(8), patient died within 2 months of initial diagnosis 
owing to aggressive nature of the disease. 
Cytogenetics 
r(8)  
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Graphical representation of r(8) dynamics in hematological malignancies. 
 
Cytogenetics morphological 
Based on the origin, ring chromosomes in 
hematological malignancies can be of two types: 
1. Ring chromosome of a single origin:  
-8, + r(8):  formation can be due to loss of telomeric 
sequences causing the reattachment of the p and q 
arms (Morgan R et al, 1985; Fugazza et al, 1996; 
Berger R et al, 2002; Oliveria F.M 2007). 
+ r(8) with two normal chromosomes 8:  It presents 
as a gain of genetic material resulting in partial 
trisomy (Keueng YK et al 1996, Edelhauser et al, 
2000, Kar B et al, 2008,Yamamoto K et al, 2013, 
Ashok V et al, 2016). Clustering of repetitive  
 
sequences resulting in amplification of critical genes 
have also been reported (Rothlisberger et al 2007, 
Koka R et al, 2016). r(8) can also comprise repetitive 
genetic sequences that results in gene amplification 
(Rothlisberger B et al, 2007). 
2. Ring chromosome of multiple origin:  Ring 
chromosomes can be derived by fusion of genetic 
material from multiple chromosomes (Sessarego et 
al 1998, Fonatsch C et al, 2001, Kim MH et al, 2001, 
Mrozek et al, 2002). Rings are also known to harbor 
fusion oncogenes such as BCR/ ABL1 (Gutierrez 
CB et al, 2016). 
r(8) has a strong association with complex 
karyotypes and clonality, resulting in relapse and 
poor clinical outcome as represented in Table 1. 
r(8) observed in this review are of singular origin. 
Majority of cases are associated with complex 
karyotypes and/or presence of multiple clones (Fig 
1) which are both indicators of genetic instability and 
disease progression. Amplification of 8q22 (D 
Gisselsson, 1999), 8q24 (Nakanishi et al, 1999) and 
co-amplification of MYB and TRBI1 (Rothlisberger 
B et al, 2006) have been observed in cases of AML. 
Inter cellular variation in size and number was 
observed in only one case, where stimulated 
lymphocyte culture yielded several clones with 
varied number and sized ring chromosome 8 (Sabine 
et al, 2013). 
Cytogenetics molecular 
Diagnostic tools such as Fluorescent In Situ 
Hybridization (FISH) and Spectral Karyotyping in 
addition to conventional cytogenetic studies have 
helped in identifying structural and functional 
characteristics such as telomere status, gene 
amplification and partial trisomy. Molecular studies 
supplement additional prognostic information, 
which is significant in understanding disease 
progression and clinical management of the patients. 
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